Approval · Notice of Compliance 30376 · 2023
DIOVAN: Notice of Compliance 30376
Issued March 22, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30376
- Date
- March 22, 2023
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph Reformatted to the Master Template. Mise á jour des étiquettes intérieures et extérieures, Mise á jour de l'encart
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIOVAN | Not yet assigned | — |